SE9103745D0 - ARYL-TRIFLATES AND RELATED COMPOUNDS - Google Patents

ARYL-TRIFLATES AND RELATED COMPOUNDS

Info

Publication number
SE9103745D0
SE9103745D0 SE9103745A SE9103745A SE9103745D0 SE 9103745 D0 SE9103745 D0 SE 9103745D0 SE 9103745 A SE9103745 A SE 9103745A SE 9103745 A SE9103745 A SE 9103745A SE 9103745 D0 SE9103745 D0 SE 9103745D0
Authority
SE
Sweden
Prior art keywords
substituted
related compounds
triflates
aryl
good
Prior art date
Application number
SE9103745A
Other languages
Swedish (sv)
Original Assignee
Wikstroem Haakan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wikstroem Haakan filed Critical Wikstroem Haakan
Priority to SE9103745A priority Critical patent/SE9103745D0/en
Publication of SE9103745D0 publication Critical patent/SE9103745D0/en
Priority to PCT/DK1992/000389 priority patent/WO1993011761A1/en
Priority to CA002126242A priority patent/CA2126242A1/en
Priority to JP5510538A priority patent/JPH08504744A/en
Priority to AU32559/93A priority patent/AU3255993A/en
Priority to EP93901666A priority patent/EP0617618A1/en
Priority to FI942931A priority patent/FI942931A0/en
Priority to NO942296A priority patent/NO942296D0/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/16—Benzazepines; Hydrogenated benzazepines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/255—Esters, e.g. nitroglycerine, selenocyanates of sulfoxy acids or sulfur analogues thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
    • C07C309/63—Esters of sulfonic acids
    • C07C309/64—Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to acyclic carbon atoms
    • C07C309/65—Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to acyclic carbon atoms of a saturated carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • C07D209/16—Tryptamines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/44—Radicals substituted by doubly-bound oxygen, sulfur, or nitrogen atoms, or by two such atoms singly-bound to the same carbon atom
    • C07D213/46—Oxygen atoms
    • C07D213/50—Ketonic radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/04—Ortho- or peri-condensed ring systems
    • C07D221/18—Ring systems of four or more rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/22—Bridged ring systems
    • C07D221/28—Morphinans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • C07D307/81—Radicals substituted by nitrogen atoms not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/14—Radicals substituted by singly bound hetero atoms other than halogen
    • C07D333/20—Radicals substituted by singly bound hetero atoms other than halogen by nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D455/00—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine
    • C07D455/02—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing not further condensed quinolizine ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09D—COATING COMPOSITIONS, e.g. PAINTS, VARNISHES OR LACQUERS; FILLING PASTES; CHEMICAL PAINT OR INK REMOVERS; INKS; CORRECTING FLUIDS; WOODSTAINS; PASTES OR SOLIDS FOR COLOURING OR PRINTING; USE OF MATERIALS THEREFOR
    • C09D11/00—Inks
    • C09D11/30—Inkjet printing inks
    • C09D11/32—Inkjet printing inks characterised by colouring agents
    • C09D11/324—Inkjet printing inks characterised by colouring agents containing carbon black
    • C09D11/326—Inkjet printing inks characterised by colouring agents containing carbon black characterised by the pigment dispersant

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Wood Science & Technology (AREA)
  • Materials Engineering (AREA)
  • Pain & Pain Management (AREA)
  • Emergency Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Aryltriflates and related compounds having general formula (1) wherein Ar is an aromatic or heteroaromatic system of a compound which has a therapeutic, biological activity when it, in the same position, carries a hydroxy, alkyloxy, halo, ester or cyano group; wherein R1 is CF3, (C1-C8)alkyl, -CH2-(C3-C8)cycloalkylalkyl, substituted phenyl, substituted benzyl, substituted phenylethyl, substituted phenylpropyl, substituted 2-thiophenylethyl or substituted 2-thiophenylpropyl; possess both good pharmacodynamic and good pharmacokinetic properties and are thus useful drugs.
SE9103745A 1991-12-18 1991-12-18 ARYL-TRIFLATES AND RELATED COMPOUNDS SE9103745D0 (en)

Priority Applications (8)

Application Number Priority Date Filing Date Title
SE9103745A SE9103745D0 (en) 1991-12-18 1991-12-18 ARYL-TRIFLATES AND RELATED COMPOUNDS
PCT/DK1992/000389 WO1993011761A1 (en) 1991-12-18 1992-12-18 Aryl-triflates and related compounds
CA002126242A CA2126242A1 (en) 1991-12-18 1992-12-18 Aryl-triflates and related compounds
JP5510538A JPH08504744A (en) 1991-12-18 1992-12-18 Aryl triflates and related compounds
AU32559/93A AU3255993A (en) 1991-12-18 1992-12-18 Aryl-triflates and related compounds
EP93901666A EP0617618A1 (en) 1991-12-18 1992-12-18 Aryl-triflates and related compounds
FI942931A FI942931A0 (en) 1991-12-18 1994-06-17 Aryl triflates and corresponding compounds
NO942296A NO942296D0 (en) 1991-12-18 1994-06-17 Aryl triflates and related compounds

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9103745A SE9103745D0 (en) 1991-12-18 1991-12-18 ARYL-TRIFLATES AND RELATED COMPOUNDS

Publications (1)

Publication Number Publication Date
SE9103745D0 true SE9103745D0 (en) 1991-12-18

Family

ID=20384643

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9103745A SE9103745D0 (en) 1991-12-18 1991-12-18 ARYL-TRIFLATES AND RELATED COMPOUNDS

Country Status (8)

Country Link
EP (1) EP0617618A1 (en)
JP (1) JPH08504744A (en)
AU (1) AU3255993A (en)
CA (1) CA2126242A1 (en)
FI (1) FI942931A0 (en)
NO (1) NO942296D0 (en)
SE (1) SE9103745D0 (en)
WO (1) WO1993011761A1 (en)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1353909B1 (en) 2000-10-31 2005-04-06 Rensselaer Polytechnic Institute 8-substituted-2,6-methano-3-benzazocines and 3-substituted morphinanes as opioidreceptor binding agents
CZ305838B6 (en) 2001-03-29 2016-04-06 Eli Lilly And Company N-(2-arylethyl)benzylamines as 5-HT6 receptor antagonists
CA2477218A1 (en) * 2002-02-27 2003-09-04 Teva Pharmaceutical Industries, Ltd. Propargylamino indan derivatives and propargylamino tetralin derivatives as brain-selective mao inhibitors
TW200744576A (en) 2006-02-24 2007-12-16 Teva Pharma Propargylated aminoindans, processes for preparation, and uses thereof
EP2094695A4 (en) * 2006-07-20 2010-04-28 Cascade Therapeutics Inc Tetrahydro-5h-pyrido[2,3-d]azepines as 5-ht2c ligands
AU2010326676B2 (en) 2009-12-04 2013-03-14 Alkermes Pharma Ireland Limited Morphinan derivatives for the treatment of drug overdose
WO2011119605A2 (en) 2010-03-22 2011-09-29 Rensselaer Polytechnic Institute Carboxamide biosiosteres of opiates
HRP20240109T1 (en) 2010-08-23 2024-03-29 Alkermes Pharma Ireland Limited Methods for treating antipsychotic-induced weight gain
US9029543B2 (en) 2011-04-05 2015-05-12 Alkermes, Inc. Process for the synthesis of quaternary amine compounds
ES2638329T3 (en) 2011-06-29 2017-10-19 Alkermes, Inc. Opioid peripheral action compounds
JP6038170B2 (en) 2011-12-15 2016-12-07 アルカーメス ファーマ アイルランド リミテッド Composition of buprenorphine and mu-opioid receptor antagonist
US9211293B2 (en) 2011-12-15 2015-12-15 Alkermes Pharma Ireland Limited Opioid agonist antagonist combinations
JO3459B1 (en) 2012-09-09 2020-07-05 H Lundbeck As Pharmaceutical compositions for treating alzheimer's disease
WO2014190270A1 (en) 2013-05-24 2014-11-27 Alkermes Pharma Ireland Limited Morphan and morphinan analogues, and methods of use
WO2014190271A2 (en) 2013-05-24 2014-11-27 Alkermes Pharma Ireland Limted Methods for treating depressive symptoms
WO2022101444A1 (en) 2020-11-12 2022-05-19 Alkermes Pharma Ireland Limited Immediate release multilayer tablet

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3725451A (en) * 1970-04-13 1973-04-03 Riker Laboratories Inc Substituted benzoylhaloalkanesulfonanilides
DE3132167A1 (en) * 1981-08-14 1983-03-03 Hoechst Ag, 6000 Frankfurt "5 (6) -PHENYLSULFONYLOXY-BENZIMIDAZOLE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF, PHARMACEUTICAL PREPARATIONS CONTAINING IT AND THEIR USE AGAINST LIVER RULES"
DE3232959A1 (en) * 1982-09-04 1984-03-08 Hoechst Ag, 6230 Frankfurt SUBSTITUTED Benzenesulfonic Acid Ester, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE AS MEDICINAL PRODUCTS
DE3243158A1 (en) * 1982-11-23 1984-05-24 Basf Ag, 6700 Ludwigshafen NEW SULPHONIC ACID ESTERS OF HYDROXYCUMARINES, THEIR PRODUCTION AND MEDICINAL PRODUCTS CONTAINING THEM
DE3247615A1 (en) * 1982-12-23 1984-07-05 Hoechst Ag, 6230 Frankfurt SUBSTITUTED PHENYLSULFONYLOXYBENZIMIDAZOLE CARBAMINATES, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE AS A MEDICINAL PRODUCT
US4470991A (en) * 1983-04-22 1984-09-11 Merck & Co., Inc. Benzothiazolesulfonamide derivatives for the topical treatment of elevated intraocular pressure
FR2557570B1 (en) * 1984-01-04 1986-04-18 Adir NEW QUINOLEIN DERIVATIVES, THEIR PREPARATION PROCESS AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
DE3509333A1 (en) * 1985-03-15 1986-09-18 Hoechst Ag, 6230 Frankfurt SUBSTITUTED BENZIMIDAZOLE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF, PHARMACEUTICAL PREPARATIONS CONTAINING THEM AND THEIR USE AS AN INGESTIC ACID INHIBITOR
DE3521761A1 (en) * 1985-06-19 1987-01-02 Bayer Ag NEW 1,4-DIHYDROPYRIDINE, METHOD FOR THE PRODUCTION AND THEIR USE IN MEDICINAL PRODUCTS
DE3630903A1 (en) * 1986-09-11 1988-03-24 Thomae Gmbh Dr K NEW TETRAHYDRONAPHTHALINE AND INDANDERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND THE MEDICINAL PRODUCTS CONTAINING THEM
GB8804016D0 (en) * 1988-02-22 1988-03-23 Boots Co Plc Therapeutic agents
DE3807813A1 (en) * 1988-03-10 1989-09-21 Thomae Gmbh Dr K NEW BENZOCYCLOHEPEN DERIVATIVES, MEDICAMENTS CONTAINING SUCH COMPOUNDS AND METHOD FOR THE PRODUCTION THEREOF
SE8901889D0 (en) * 1989-05-26 1989-05-26 Astra Ab NOVEL 8-SUBSTITUTED-2-AMINOTETRALINES
SE8904361D0 (en) * 1989-12-22 1989-12-22 Astra Ab NEW CHROMAN AND THIOCHROMAN DERIVATIVES
KR920004385A (en) * 1990-08-09 1992-03-27 와꾸나가 기스께 New tricyclic compounds or salts thereof, preparation method thereof and antimicrobial agent containing same

Also Published As

Publication number Publication date
AU3255993A (en) 1993-07-19
JPH08504744A (en) 1996-05-21
CA2126242A1 (en) 1993-06-24
FI942931A (en) 1994-06-17
WO1993011761A1 (en) 1993-06-24
NO942296L (en) 1994-06-17
NO942296D0 (en) 1994-06-17
EP0617618A1 (en) 1994-10-05
FI942931A0 (en) 1994-06-17

Similar Documents

Publication Publication Date Title
SE9103745D0 (en) ARYL-TRIFLATES AND RELATED COMPOUNDS
PT976760E (en) OLIGOPEPTIDOS WITH FUNGICIDAL ACTIVITY
EP0639572A4 (en) 2-(2,6-difluorophenyl)-4-(2-ethoxy-4-tert-butylphenyl)-2-oxazoline.
PH30006A (en) 9-¬(Substituted glycol)amido¾-6.demethyl-6-deoxytetra-cyclines
DE69407409T2 (en) AZOLYLAMINE DERIVATIVE
FI940355A (en) Compounds having anti-angiotensin II activity
EP0945439A4 (en) Novel aminopyrazole derivatives
IL113011A (en) R-mandelic acid salt of (2s,3s)-3- (2-methoxybenzylamino)-2- phenylpiperidine
ZA916268B (en) Tricyclic compound or salts thereof,method for producing the same and antimicrobial agent containing the same
NO903640D0 (en) PROCEDURE FOR THE PREPARATION OF 2- (RS) -SUBSTITUTED 2,3-DIHYDRO-5-OXY-4,6,7-TRIMETHYL BENZOFURANES.
IT8921492A0 (en) PROCEDURE FOR THE OXIDATION OF PARAFFINIC COMPOUNDS.
DE69312776T2 (en) Fungicidal 3,4-diaryl- (5H) -uran-2-one derivative
AU740079C (en) Antirheumatic agents
AU7095891A (en) Novel 3-substituted pyridinemethanols, and fungicides containing them
IT1278311B1 (en) DRAWER GUIDE FOR DRAWERS.
IT1278319B1 (en) DRAWER GUIDE FOR DRAWERS.
IT1277526B1 (en) DRAWER STRUCTURE WITH HIGH SLIDING PRECISION FOR FURNITURE COMPONENTS
FR2658643B1 (en) MAGNETIC INFORMATION PANEL SUPPORT.
ZA929195B (en) 2-(heteroaryloxyphenoxy) alkylsulfonates useful as herbicidal agents.
KR950009784U (en) Image compensation device when searching for still image discs
KR950009795U (en) Support spring for video cassette tape
KR900016181U (en) Support spring for video cassette
ES1025321Y (en) VERTICAL CALSIFIER FOR VIDEO TAPES.
ITMI911844A1 (en) SIMPLIFIED PROCEDURE FOR FOOTWEAR ASSEMBLY
KR950012488U (en) V-Cal's cassette storage door switch